Several studies have shown that genetic and pharmacological CB1 blockade increases sympathetic drive in adipose tissues, protecting against diet-induced obesity [23,25,56,57,58]. The gene discussed is CNR1; the disease is obesity due to melanocortin 4 receptor deficiency.